Mr. Bitterman has served as Interim Chief Executive Officer since September 2022. Mr. Bitterman will continue to serve as Chair of the Board, and as the Company’s principal executive officer and principal financial officer.
Phio Pharmaceuticals Names Robert Bitterman As President & CEO, Effective February 20, 2023
Mr. Bitterman has served as Interim Chief Executive Officer since September 2022. Mr. Bitterman will continue to serve as Chair of the Board, and as the Company's principal executive officer and principal
